dipyridamole has been researched along with osteoprotegerin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avignon, A; Cristol, JP; Dupuy, AM; Elaerts, S; Piot, C; Sultan, A | 1 |
1 other study(ies) available for dipyridamole and osteoprotegerin
Article | Year |
---|---|
Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.
Topics: Adrenergic beta-Agonists; Aged; Biomarkers; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipyridamole; Electrocardiography; Exercise Test; Female; Glycated Hemoglobin; Glycoproteins; Humans; Lipids; Male; Middle Aged; Multivariate Analysis; Osteoprotegerin; Platelet Aggregation Inhibitors; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Risk Factors | 2005 |